ECG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 8 of 9 cases where ECG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ECG's RSI Indicator exited the oversold zone, 4 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +9.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECG advanced for three days, in 105 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECG as a result. In 28 of 40 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for ECG turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 12 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
ECG moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ECG crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for ECG entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.059) is normal, around the industry mean (14.908). P/E Ratio (15.382) is within average values for comparable stocks, (166.230). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.207) among similar stocks. P/S Ratio (1.335) is also within normal values, averaging (2.856).
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. ECG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Aroon Indicator for MYRG entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 156 similar instances where the Aroon Indicator formed such a pattern. In 119 of the 156 cases the stock moved lower. This puts the odds of a downward move at 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 74 cases where MYRG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for MYRG turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 35 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
MYRG moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MYRG crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYRG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MYRG's RSI Oscillator exited the oversold zone, 17 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MYRG as a result. In 68 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
Following a +6.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYRG advanced for three days, in 243 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
MYRG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.426) is normal, around the industry mean (14.908). P/E Ratio (24.756) is within average values for comparable stocks, (166.230). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.207) among similar stocks. P/S Ratio (1.079) is also within normal values, averaging (2.856).
The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MYRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MYRG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 58 | |
SMR RATING 1..100 | 39 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 82 | |
SEASONALITY SCORE 1..100 | 32 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ECG | MYRG | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 80% | 3 days ago 68% |
| Stochastic ODDS (%) | 3 days ago 88% | 3 days ago 69% |
| Momentum ODDS (%) | 3 days ago 70% | 3 days ago 75% |
| MACD ODDS (%) | 3 days ago 57% | 3 days ago 69% |
| TrendWeek ODDS (%) | 3 days ago 68% | 3 days ago 71% |
| TrendMonth ODDS (%) | 3 days ago 85% | 3 days ago 75% |
| Advances ODDS (%) | 6 days ago 86% | 11 days ago 73% |
| Declines ODDS (%) | 4 days ago 67% | 4 days ago 71% |
| BollingerBands ODDS (%) | 3 days ago 89% | 3 days ago 77% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 76% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ECG’s FA Score shows that 1 FA rating(s) are green while MYRG’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ECG’s TA Score shows that 4 TA indicator(s) are bullish while MYRG’s TA Score has 4 bullish TA indicator(s).
ECG (@Engineering & Construction) experienced а -25.36% price change this week, while MYRG (@Engineering & Construction) price change was -6.97% for the same time period.
The average weekly price growth across all stocks in the @Engineering & Construction industry was -7.70%. For the same industry, the average monthly price growth was -15.73%, and the average quarterly price growth was -32.82%.
MYRG is expected to report earnings on Mar 03, 2027.
Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
A.I.dvisor indicates that over the last year, MYRG has been closely correlated with PWR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if MYRG jumps, then PWR could also see price increases.
| Ticker / NAME | Correlation To MYRG | 1D Price Change % | ||
|---|---|---|---|---|
| MYRG | 100% | +6.62% | ||
| PWR - MYRG | 79% Closely correlated | +6.25% | ||
| FIX - MYRG | 78% Closely correlated | +5.45% | ||
| EME - MYRG | 73% Closely correlated | +2.21% | ||
| ECG - MYRG | 69% Closely correlated | +5.74% | ||
| STRL - MYRG | 68% Closely correlated | +3.47% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DNOV | 52.39 | 0.15 | +0.29% |
| FT Vest U.S. Equity Deep Buffer ETF - November (DNOV) | |||
| SBB | 23.85 | N/A | N/A |
| ProShares Short SmallCap600 (SBB) | |||
| ATTR | 95.80 | -0.13 | -0.14% |
| Arin Tactical Tail Risk ETF | |||
| DSTL | 69.60 | -0.93 | -1.32% |
| Distillate US Fundamental Stability & Value ETF (DSTL) | |||
| HOMZ | 43.67 | -0.78 | -1.77% |
| Hoya Capital Housing ETF (HOMZ) | |||